Newsletter #3

Editorial

Editorial

Editorial by Prof Nikolaos Papanikolaou, Scientific manager of the ProCAncer-I project ProCAncer-I is a collaborative project that combines the efforts of 20 clinical and technical partners in Europe and US. The focus is to collect the biggest in size, diverse dataset...

read more
The Annotation tool

The Annotation tool

by Quibim Quibim set out to transform prostate diagnosis and monitoring by developing a new non-invasive imaging tool using MRI data and advanced computer models to investigate the prostate anatomy in extreme detail. The company has developed AI algorithms for...

read more

Curating the data curation tool

by Advantis Medical Imaging   Curating datasets is not an easy task. On the contrary, it can bring about hard-to-solve problems and lead to open-ended discussions, until a  satisfactory solution is found. In ProCAncer-I, the curation of medical images has been a...

read more

Advisory Board

Prof. Vincenzo Valentini is Professor of Radiation Oncology at the Faculty of Medicine of the Università Cattolica S.Cuore in Rome and Director of the Department of Radiology, Radiation Oncology and Haematology at the Policlinico Universitario A.Gemelli-IRCCS in Rome....

read more

Newsletter #3 Contents

Highlights

ProCAncer-I at the EMUC24 in Lisbon

ProCAncer-I at the EMUC24 in Lisbon

The progress of major trials, the advent of artificial intelligence (AI), and interdisciplinary best practices will comprise the scientific programme of the 16th European Multidisciplinary Congress on Urological Cancers (EMUC24), which will take place from 7 to 10...

Third Dissemination Event of the ProCAncer-I Project in Athens

Third Dissemination Event of the ProCAncer-I Project in Athens

ProCAncer-I organised the 3rd Dissemination Event of the project at the 21st IEEE International Symposium on Biomedical Imaging, held in Athens, Greece, May 27-30, 2024. During the symposium, ProCAncer-I organised the Workshop “Integrating imaging Data and AI models...

AI in PCa imaging : The current status and future perspectives

AI in PCa imaging : The current status and future perspectives

Ιn recent years, magnetic resonance imaging (MRI) has transformed the prostate cancer (PCa) diagnostic pathway, based on the evidence of multiple high-level evidence studies (refs 4M, MRI first, and PROMIS). Taken together, the evidence indicates that prostate MRI...

Twitter feed is not available at the moment.

Stay in touch!